TTM
$1.88
YoY change
-73.7%
5Y CAGR
+7.1%
Peak year (2024)
$6.97
Latest annual
$1.83
EPS (Diluted) history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $1.83
EPS (Diluted) growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: -73.7%
EPS (Diluted) history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $1.83 | -73.7% | −$5.14 | ||
| 2024 | $6.97 | +203.0% | +$4.67 | ||
| 2023 | $2.30 | -5.7% | −$0.14 | ||
| 2022 | $2.44 | +2.5% | +$0.06 | ||
| 2021 | $2.38 | +83.1% | +$1.08 | ||
| 2020 | $1.30 | -20.7% | −$0.34 | ||
| 2019 | $1.64 | +45.1% | +$0.51 | ||
| 2018 | $1.13 | +17.7% | +$0.17 | ||
| 2017 | $0.96 | +10.3% | +$0.09 | ||
| 2016 | $0.87 | +16.0% | +$0.12 | ||
| 2015 | $0.75 | -40.0% | −$0.50 | ||
| 2014 | $1.25 | +119.3% | +$0.68 | ||
| 2013 | $0.57 | +39.0% | +$0.16 | ||
| 2012 | $0.41 | +24.2% | +$0.08 | ||
| 2011 | $0.33 | +6.5% | +$0.02 | ||
| 2010 | $0.31 | -6.1% | −$0.02 | ||
| 2009 | $0.33 | +83.3% | +$0.15 | ||
| 2008 | $0.18 | +12.5% | +$0.02 | ||
| 2007 | $0.16 | -11.1% | −$0.02 | ||
| 2006 | $0.18 | +63.6% | +$0.07 | ||
| 2005 | $0.11 | +4300.0% | +$0.11 | ||
| 2004 | $0.00 | -97.7% | −$0.11 | ||
| 2003 | $0.11 | +45.1% | +$0.03 | ||
| 2002 | $0.08 | -545.9% | +$0.09 | ||
| 2001 | −$0.02 | -95.6% | +$0.37 | ||
| 2000 | −$0.39 | -425.0% | −$0.51 | ||
| 1999 | $0.12 | — | — |
- 2025$1.83-73.7%
- 2024$6.97+203.0%
- 2023$2.30-5.7%
- 2022$2.44+2.5%
- 2021$2.38+83.1%
- 2020$1.30-20.7%
- 2019$1.64+45.1%
- 2018$1.13+17.7%
- 2017$0.96+10.3%
- 2016$0.87+16.0%
- 2015$0.75-40.0%
- 2014$1.25+119.3%
- 2013$0.57+39.0%
- 2012$0.41+24.2%
- 2011$0.33+6.5%
- 2010$0.31-6.1%
- 2009$0.33+83.3%
- 2008$0.18+12.5%
- 2007$0.16-11.1%
- 2006$0.18+63.6%
- 2005$0.11+4300.0%
- 2004$0.00-97.7%
- 2003$0.11+45.1%
- 2002$0.08-545.9%
- 2001−$0.02-95.6%
- 2000−$0.39-425.0%
- 1999$0.12—
EPS (Diluted) values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current diluted EPS (TTM) is $1.88. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) diluted EPS is $1.83 – plunged 73.7% year-over-year.
Over 2020–2025 (5 years), Edwards Lifesciences diluted EPS expanded at a +7.1% compound annual rate, with mixed annual results across the window.
Edwards Lifesciences diluted EPS peaked at $6.97 in 2024; the latest annual figure is $1.83 in 2025 (73.7% below peak).
2024 marks the peak diluted EPS at $6.97, with the historical low of −$0.39 recorded in 2000.
Edwards Lifesciences EPS (Diluted) by Year
Edwards Lifesciences EPS (Diluted) 2025: $1.83
Edwards Lifesciences posted diluted EPS of $1.83 in 2025, plunged 73.7% below 2024.
Edwards Lifesciences EPS (Diluted) 2024: $6.97
In 2024, Edwards Lifesciences reported diluted EPS of $6.97, surged 203.0% from 2023. This figure represents the highest annual value in the available history.
Edwards Lifesciences EPS (Diluted) 2023: $2.30
Edwards Lifesciences diluted EPS in 2023 was $2.30, declined 5.7% below 2022.
Edwards Lifesciences EPS (Diluted) 2022: $2.44
2022's diluted EPS for Edwards Lifesciences came in at $2.44, edged up 2.5% from 2021.
Edwards Lifesciences EPS (Diluted) 2021: $2.38
Edwards Lifesciences diluted EPS in 2021 was $2.38.
See more financial history for Edwards Lifesciences (EW). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation